Disease Landscape and Forecast Insights
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Psoriasis | Treatment Algorithms: Claims Data Analysis | Adult Psoriasis | US | 2020
The adult psoriasis market has become increasingly lucrative owing to the growing use of biologics in the moderate to severe population, which cannot be adequately controlled with conventional…
Asthma | Treatment Algorithms: Claims Data Analysis | Pediatric Asthma | US | 2020
Pediatric asthma is treated using two types of pharmacotherapies: rescue therapy for acute symptoms via bronchodilation (e.g., a SABA) and maintenance therapy to prevent exacerbations by targeting…
Urticaria | Treatment Algorithms: Claims Data Analysis | Chronic Spontaneous | US | 2020
Chronic spontaneous urticaria (CSU), also known as chronic idiopathic urticaria, presents as hives that persist daily or almost daily for six weeks or longer without an obvious known stimulus. Drug…
Biosimilars | Market Events and Forecast Landscape | Overview of Biosimilar Forecasts | US/EU | 2020
In 2019, sales of branded biologics in oncology, immunology, endocrinology, nephrology, respiratory, and ophthalmology exceeded $100 billion in the major pharmaceutical markets under study (United…